Results 31 to 40 of about 11,403 (144)

Lyme disease and the pursuit of a clinical cure

Frontiers in Medicine, 2023
Lyme disease, caused by the spirochete Borrelia burgdorferi, is the most common vector-borne illness in the United States. Many aspects of the disease are still topics of controversy within the scientific and medical communities.
Heather Adkison, Monica E. Embers
doaj   +1 more source

Cognitive Decline in Post-treatment Lyme Disease Syndrome [PDF]

Archives of Clinical Neuropsychology, 2018
Patient-reported cognitive complaints are common in those with post-treatment Lyme disease syndrome (PTLDS). Objective evidence of cognitive impairment in this population is variable in part due to methodological variability in existing studies. In this study, we sought to use a systematic approach to characterizing PTLDS based on the most current ...
Pegah, Touradji, John N, Aucott, Ting, Yang, Alison W, Rebman, Kathleen T, Bechtold   +4 more
openaire   +2 more sources

Outpatient visits before and after Lyme disease diagnosis in a Maryland employer-based health plan

BMC Health Services Research, 2023
Background Insurance claims data have been used to inform an understanding of Lyme disease epidemiology and cost of care, however few such studies have incorporated post-treatment symptoms following diagnosis.
Alison W. Rebman, Ting Yang, Lin Wang, Jill A. Marsteller, Shannon M. E. Murphy, Maria Uriyo, John N. Aucott   +6 more
doaj   +1 more source

Non-specific symptoms and post-treatment Lyme disease syndrome in patients with Lyme borreliosis: a prospective cohort study in Belgium (2016-2020). [PDF]

BMC Infect Dis, 2022
Abstract Background Patients with Lyme borreliosis (LB) may report persisting non-specific symptoms such as fatigue, widespread musculoskeletal pain or cognitive difficulties. When present for more than 6 months and causing a reduction in daily activities, this is often referred to as post-treatment Lyme disease syndrome
Geebelen L, Lernout T, Devleesschauwer B, Kabamba-Mukadi B, Saegeman V, Belkhir L, De Munter P, Dubois B, Westhovens R, Humtick Hospital Group, Van Oyen H, Speybroeck N, Tersago K.   +12 more
europepmc   +8 more sources

Neuropsychiatric Lyme Disease and Vagus Nerve Stimulation

Antibiotics, 2023
Lyme disease, the most common tick-borne disease in the United States, is caused by infection with the spirochete Borrelia burgdorferi. While most patients with acute Lyme disease recover completely if treated with antibiotics shortly after the onset of ...
Nicholas Biniaz-Harris, Mara Kuvaldina, Brian A. Fallon   +2 more
doaj   +1 more source

Probable late lyme disease: a variant manifestation of untreated Borrelia burgdorferi infection

BMC Infectious Diseases, 2012
Background Lyme disease, a bacterial infection with the tick-borne spirochete Borrelia burgdorferi, can cause early and late manifestations. The category of probable Lyme disease was recently added to the CDC surveillance case definition to describe ...
Aucott John N, Seifter Ari, Rebman Alison W   +2 more
doaj   +1 more source

Neurocognition in Post-Treatment Lyme Disease and Major Depressive Disorder [PDF]

Archives of Clinical Neuropsychology, 2018
Neurocognitive dysfunction in patients with residual or emergent symptoms after treatment for Lyme Disease is often attributed to comorbid depression. In this study, patients with Post-Treatment Lyme Disease Syndrome (PTLDS) were compared to patients with Major Depressive Disorder (MDD), as well as healthy comparison subjects (HC), on neurocognitive ...
John G, Keilp, Kathy, Corbera, Marianne, Gorlyn, Maria A, Oquendo, J John, Mann, Brian A, Fallon   +5 more
openaire   +2 more sources

Longitudinal Transcriptome Analysis Reveals a Sustained Differential Gene Expression Signature in Patients Treated for Acute Lyme Disease

mBio, 2016
Lyme disease is a tick-borne illness caused by the bacterium Borrelia burgdorferi, and approximately 10 to 20% of patients report persistent symptoms lasting months to years despite appropriate treatment with antibiotics.
Jerome Bouquet, Mark J. Soloski, Andrea Swei, Chris Cheadle, Scot Federman, Jean-Noel Billaud, Alison W. Rebman, Beniwende Kabre, Richard Halpert, Meher Boorgula, John N. Aucott, Charles Y. Chiu   +11 more
doaj   +1 more source

Risk Factors and Outcomes of Treatment Delays in Lyme Disease: A Population-Based Retrospective Cohort Study

Frontiers in Medicine, 2020
Background: Longer time between symptom onset and treatment of Lyme disease has been associated with poor outcomes. Reducing time-to-treatment requires knowledge of risks for treatment delays.
Annemarie G. Hirsch, Melissa N. Poulsen, Cara Nordberg, Katherine A. Moon, Alison W. Rebman, John N. Aucott, Christopher D. Heaney, Christopher D. Heaney, Christopher D. Heaney, Brian S. Schwartz, Brian S. Schwartz   +10 more
doaj   +1 more source

Immune Responses to Some Viral Infections That Have a High Evolutionary Potential—A Case Report with Literature Review

Life, 2022
Viral infections are a key issue in modern medicine. SARS-CoV-2 infection confirms that we are not sufficiently prepared for these unforeseen infections. The COVID-19 pandemic has cultivated a great sense of fear and distrust in patients.
Maria Lucia Sur, Bogdan-Stefan Moldovan, Diana Mocanu, Gabriel Samasca, Iulia Lupan, Ionel Armat, Marin Harabagiu, Genel Sur, Calin Lazar   +8 more
doaj   +1 more source